A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2004
11/10/2004	CN1543820A Method for manufacturing glycosaminoglycan film-forming agent for fresh-keeping of winter jujube
11/10/2004	CN1543819A Method for manufacturing carboxymethyl glycosaminoglycan film-forming agent for fresh-keeping of winter jujube
11/10/2004	CN1543818A Method for manufacturing hydroxyethyl glycosaminoglycan film-forming agent for fresh-keeping of winter jujube
11/10/2004	CN1175105C Purification of vitamin-K dependent proteins by membrane chromatography
11/10/2004	CN1174772C Composite medicine for treating cancer of esophagus
11/10/2004	CN1174770C External medicine for curing gynaecological inflammation and its preparing method
11/10/2004	CN1174768C Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylosis and intervertebral disk protrusion and its preparation method
11/10/2004	CN1174766C Chinese medicine beautifying pellet and its compounding process
11/10/2004	CN1174764C Externally applied medicinal wine for curing Buerger disease
11/10/2004	CN1174762C Compound Chinese medicine preparation for curing cervical spondylotic myelopathy and cervical spondylotic radiculopathy
11/10/2004	CN1174761C Medicine composition for treating echinococcosis and its preparing process
11/10/2004	CN1174759C External application ointment for curing sterility and its preparation method
11/10/2004	CN1174757C Formulation and production process of royal jelly soft-capsule
11/10/2004	CN1174756C Process for preparing medicine for treating cerebral thrombus and its sequelae
11/10/2004	CN1174755C Method for preparing artificial bear bile powder
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815203 Methods of making pancreatic islet cells
11/09/2004	US6815202 A homogenous cell mixture spontaneously sorting to form discrete first and second layers, e.g. keratinocytes and fibroblasts, and having a connective tissue component; skin grafts: testing a response to a chemical or a drug
11/09/2004	US6815200 Modified adenovirus containing a fiber replacement protein
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	CA2428268A1 Chewable calf liver tablet specially designed to reduce fur loss and skin problems in cats and dogs
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094619A2 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094588A2 Postnatal stem cells and uses thereof
11/04/2004	WO2004093932A1 A seeded tear resistant scaffold
11/04/2004	WO2004093899A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	WO2004093890A2 Pharmaceutical composition comprising bioelement (enzyme and factor)
11/04/2004	WO2004093846A2 Charged initiator polymers and methods of use
11/04/2004	WO2004093646A2 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/04/2004	WO2004053101A3 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
11/04/2004	WO2004052177A3 Cell-based therapies for ischemia
11/04/2004	WO2004047747A3 Compositions and methods for cell dedifferentiation and tissue regeneration
11/04/2004	WO2004045493A3 Methods of inducing or enhancing cartilage repair
11/04/2004	WO2004030628A3 Adult bone marrow derived stem cells
11/04/2004	WO2004005492A3 Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003100026A3 Methods, compositions, and growth and differentiation factors for insulin-producing cells
11/04/2004	WO2003092612A3 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	US20040220619 Method of inhibiting the proliferation of vascular smooth muscle cells
11/04/2004	US20040220124 antitumor agents; insertion of parvirus into brain
11/04/2004	US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004	US20040220089 Ophthalmic preparation containing glycoprotein
11/04/2004	US20040220082 Parkinson's disease; central nervous system disorders; reducing activation of Kv3.4 protein
11/04/2004	US20040220076 Prevention of recurrent viral disease
11/04/2004	US20040219666 Culturing neuronal cells in presence of neurite/adhesive projections inhibitor for enhancing viability of neuronal transplantation cells; tissue engineering and treatment of nervous system injury; grafting
11/04/2004	US20040219551 Comprises nucleotide sequences coding epithelial stromal interaction 1 (EPSTI-1) protein for use in tumor diagnosis and identifying modulators for treatment of cell prolifefrative and viral disorders
11/04/2004	US20040219519 Method for bacteriophage delivery and amplification
11/04/2004	US20040219226 Complex prescription of Chinese medicine for the treatment of extensive cancer
11/04/2004	US20040219168 Preparing preferential cells from blood mononucler cells in culture; obtain monocytes, incubate with interferon; use as biodrugs treating viral infections, lymphoma, neoplastic disease induced by Epstein-Barr virus, therapeutic vaccination
11/04/2004	US20040219167 Herpes viruses for immune modulation
11/04/2004	US20040219160 Zwitterionic immunomodulators for the treatment of asthma and allergy
11/04/2004	US20040219157 Composition comprising a prebiotic for decreasing inflammatory process and abnormal actibation of non-specific immune parameters
11/04/2004	US20040219153 Synergistic tumorcidal response induced by histamine
11/04/2004	US20040219136 Use of umbilical cord blood to treat individuals having a disease, disorder or condition
11/04/2004	US20040219135 Anti-transforming growth factor beta (TGF-beta) treated stem cell composition and method
11/04/2004	US20040219134 implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues
11/04/2004	US20040219133 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue
11/04/2004	CA2816907A1 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
11/04/2004	CA2809164A1 Postnatal stem cells and uses thereof
11/04/2004	CA2528503A1 Tolerance to graft prior to thymic regeneration
11/04/2004	CA2527041A1 Reprogramming nuclear function with somatic cell cytoplasm
11/04/2004	CA2523377A1 Influence of genotype on susceptibility to treatment with fish oil
11/04/2004	CA2522743A1 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
11/04/2004	CA2522727A1 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/04/2004	CA2522669A1 Postnatal stem cells and uses thereof
11/04/2004	CA2522581A1 A seeded tear resistant scaffold
11/04/2004	CA2520968A1 Charged initiator polymers and methods of use
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1472933A1 Improving health and/or nutritional status of an aquatic animal by aid of Bacillus licheniformis
11/03/2004	EP1472343A2 Method for the production of a nerve transplant
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472340A1 Lineage committed stem cells selected for telomerase promoter activity
11/03/2004	EP1472270A1 Fractionation of phytosterol esters in oil
11/03/2004	EP1472021A2 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471940A2 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitisers
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1121929B1 Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions
11/03/2004	EP0927023B1 Composition for treating acne
11/03/2004	EP0921813B1 Immunogenic preparation and method for improving the productivity of ruminant animals
11/03/2004	EP0888118B1 Enhancement of microbial colonisation of the gastrointestinal tract
11/03/2004	EP0729325B1 Osteogenic product and use
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
11/03/2004	CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes
11/03/2004	CN1543500A Cardiomyocyte precursors from human embryonic stem cells
11/03/2004	CN1543440A Medical grade water production system
11/03/2004	CN1543353A Composition for treatment of articular cartilage damage
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1541714A Gene transfer-mediated angiogenesis therapy
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541707A Medicinal composition for treating serious acute respiratory syndrome

1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 1259